Filing Details
- Accession Number:
- 0001209191-17-036156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-30 17:06:43
- Reporting Period:
- 2017-05-25
- Filing Date:
- 2017-05-30
- Accepted Time:
- 2017-05-30 17:06:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640500 | Jennifer Balliet | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | Vp And Chief Culture Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-05-26 | 3,334 | $7.50 | 10,049 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock | Acquisiton | 2017-05-25 | 20,000 | $0.00 | 20,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,000 | 2018-05-25 | No | 4 | A | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $3.76 | 2014-04-16 | 2018-04-16 | 7,500 | 7,500 | Direct |
Common Stock | Stock Option (Right to Buy) | $3.45 | 2015-03-05 | 2019-03-05 | 15,000 | 15,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $4.78 | 2016-05-04 | 2020-05-04 | 120,000 | 120,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $7.15 | 2017-04-20 | 2021-04-20 | 50,000 | 50,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $7.52 | 2018-04-28 | 2022-04-28 | 60,000 | 60,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2018-04-16 | 7,500 | 7,500 | Direct |
2019-03-05 | 15,000 | 15,000 | Direct |
2020-05-04 | 120,000 | 120,000 | Direct |
2021-04-20 | 50,000 | 50,000 | Direct |
2022-04-28 | 60,000 | 60,000 | Direct |
Footnotes
- On April 16, 2013, Jennifer Balliet was granted 7,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- On March 5, 2014, Jennifer Balliet was granted 15,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date.
- Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- Restricted stock will vest as follows; 6,666 units will vest on May 25, 2018 and 6,667 units will vest on May 25, 2019 and 2020.
- These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.